Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Osteocyte morphology and orientation in relation to strain in the jaw bone.

Wu V, van Oers RFM, Schulten EAJM, Helder MN, Bacabac RG, Klein-Nulend J.

Int J Oral Sci. 2018 Feb 26;10(1):2. doi: 10.1038/s41368-017-0007-5.

2.

Comparison of gamma- and DVH-based in vivo dosimetric plan evaluation for pelvic VMAT treatments.

van der Bijl E, van Oers RFM, Olaciregui-Ruiz I, Mans A.

Radiother Oncol. 2017 Dec;125(3):405-410. doi: 10.1016/j.radonc.2017.09.014. Epub 2017 Oct 7.

PMID:
29017719
3.

Virtual patient 3D dose reconstruction using in air EPID measurements and a back-projection algorithm for IMRT and VMAT treatments.

Olaciregui-Ruiz I, Rozendaal R, van Oers RFM, Mijnheer B, Mans A.

Phys Med. 2017 May;37:49-57. doi: 10.1016/j.ejmp.2017.04.016. Epub 2017 Apr 21.

PMID:
28535915
4.

Abutment-to-fixture load transfer and peri-implant bone stress.

Van Oers RF, Feilzer AJ.

Am J Dent. 2015 Oct;28(5):247-50.

PMID:
26714340
5.

Osteocyte shape and mechanical loading.

van Oers RF, Wang H, Bacabac RG.

Curr Osteoporos Rep. 2015 Apr;13(2):61-6. doi: 10.1007/s11914-015-0256-1. Review.

6.

Bone cell mechanosensitivity, estrogen deficiency, and osteoporosis.

Klein-Nulend J, van Oers RF, Bakker AD, Bacabac RG.

J Biomech. 2015 Mar 18;48(5):855-65. doi: 10.1016/j.jbiomech.2014.12.007. Epub 2014 Dec 29. Review.

PMID:
25582356
7.

Mechanical cell-matrix feedback explains pairwise and collective endothelial cell behavior in vitro.

van Oers RF, Rens EG, LaValley DJ, Reinhart-King CA, Merks RM.

PLoS Comput Biol. 2014 Aug 14;10(8):e1003774. doi: 10.1371/journal.pcbi.1003774. eCollection 2014 Aug.

8.

Nitric oxide signaling in mechanical adaptation of bone.

Klein-Nulend J, van Oers RF, Bakker AD, Bacabac RG.

Osteoporos Int. 2014 May;25(5):1427-37. doi: 10.1007/s00198-013-2590-4. Epub 2013 Dec 10. Review.

PMID:
24322479
9.

Osteocyte-viability-based simulations of trabecular bone loss and recovery in disuse and reloading.

Wang H, Ji B, Liu XS, van Oers RF, Guo XE, Huang Y, Hwang KC.

Biomech Model Mechanobiol. 2014 Jan;13(1):153-66. doi: 10.1007/s10237-013-0492-1. Epub 2013 Apr 13.

PMID:
23584331
10.

Electronic nose technology for detection of invasive pulmonary aspergillosis in prolonged chemotherapy-induced neutropenia: a proof-of-principle study.

de Heer K, van der Schee MP, Zwinderman K, van den Berk IA, Visser CE, van Oers R, Sterk PJ.

J Clin Microbiol. 2013 May;51(5):1490-5. doi: 10.1128/JCM.02838-12. Epub 2013 Mar 6.

11.

Simulations of trabecular remodeling and fatigue: is remodeling helpful or harmful?

van Oers RF, van Rietbergen B, Ito K, Huiskes R, Hilbers PA.

Bone. 2011 May 1;48(5):1210-5. doi: 10.1016/j.bone.2011.01.011. Epub 2011 Jan 21.

PMID:
21256994
12.

A sclerostin-based theory for strain-induced bone formation.

van Oers RF, van Rietbergen B, Ito K, Hilbers PA, Huiskes R.

Biomech Model Mechanobiol. 2011 Oct;10(5):663-70. doi: 10.1007/s10237-010-0264-0. Epub 2010 Nov 11.

PMID:
21069416
13.

Reversible posterior leucoencephalopathy syndrome associated with bortezomib in a patient with relapsed multiple myeloma.

Kager LM, Kersten MJ, Kloppenborg RP, Van Oers R, Van den Born BJ.

BMJ Case Rep. 2009;2009. pii: bcr06.2009.1926. doi: 10.1136/bcr.06.2009.1926. Epub 2009 Oct 12.

14.

Relating osteon diameter to strain.

van Oers RF, Ruimerman R, van Rietbergen B, Hilbers PA, Huiskes R.

Bone. 2008 Sep;43(3):476-82. doi: 10.1016/j.bone.2008.05.015. Epub 2008 May 28.

PMID:
18619937
15.

A unified theory for osteonal and hemi-osteonal remodeling.

van Oers RF, Ruimerman R, Tanck E, Hilbers PA, Huiskes R.

Bone. 2008 Feb;42(2):250-9. Epub 2007 Oct 23.

PMID:
18063436
16.

Management of AIDS-related non-Hodgkin's lymphomas.

Kersten MJ, Van Oers RH.

Drugs. 2001;61(9):1301-15. Review.

PMID:
11511024
17.

Effect of locally applied GM-CSF on oral mucositis after stem cell transplantation: a prospective placebo-controlled double-blind study.

van der Lelie H, Thomas BL, van Oers RH, Ek-Post M, Sjamsoedin SA, van Dijk-Overtoom ML, Timmer JG, von dem Borne AE.

Ann Hematol. 2001 Mar;80(3):150-4.

PMID:
11320899
18.

Molecular analysis of critical sequences within the EBNA-2 type 1 gene from Epstein-Barr virus isolates from patients with infectious mononucleosis, tonsillar hyperplasia, and HIV infection.

Al-Homsi AS, Berger C, van Baarle D, Kersten MJ, Klein MR, McQuain C, van Oers R, Knecht H.

Int J Mol Med. 1998 Jun;1(6):983-7.

PMID:
9852635
19.

Carboxy terminal variants of Epstein-Barr virus-encoded latent membrane protein 1 during long-term human immunodeficiency virus infection: reliable markers for individual strain identification.

Berger C, van Baarle D, Kersten MJ, Klein MR, Al-Homsi AS, Dunn B, McQuain C, van Oers R, Knecht H.

J Infect Dis. 1999 Jan;179(1):240-4.

PMID:
9841847
20.

Antigen receptor function in chronic lymphocytic leukemia B cells.

Lankester AC, Schijndel GM, Pakker NG, Van Oers RH, van Lier RA.

Leuk Lymphoma. 1996 Dec;24(1-2):27-33. Review.

PMID:
9049959
21.

A single dose of granulocyte-macrophage colony-stimulating factor induces systemic interleukin-8 release and neutrophil activation in healthy volunteers.

van Pelt LJ, Huisman MV, Weening RS, von dem Borne AE, Roos D, van Oers RH.

Blood. 1996 Jun 15;87(12):5305-13.

PMID:
8652846
22.

99mTc-CD19 monoclonal antibody is not useful for imaging of B cell non-Hodgkin's lymphoma.

Vervoordeldonk SF, Heikens J, Goedemans WT, Merle PA, von dem Borne AE, van Royen EA, Slaper-Cortenbach IC, van Oers RH.

Cancer Immunol Immunother. 1996 Jun;42(5):291-6.

PMID:
8706051
23.

Elevation of cerebrospinal fluid soluble CD27 levels in patients with meningeal localization of lymphoid malignancies.

Kersten MJ, Evers LM, Dellemijn PL, van den Berg H, Portegies P, Hintzen RQ, van Lier RA, von dem Borne AE, van Oers RH.

Blood. 1996 Mar 1;87(5):1985-9. Erratum in: Blood 1996 Oct 1;88(7):2818.

PMID:
8634448
24.

Intermediate-dose melphalan (IDM) combined with G-CSF (filgrastim) is an effective and safe induction therapy for autologous stem cell transplantation in multiple myeloma.

Lokhorst HM, Sonneveld P, Wijermans PW, van Marwijk Kooy M, Meuwissen OJ, van Oers RH, van der Griend R, Dekker AW.

Br J Haematol. 1996 Jan;92(1):44-8.

PMID:
8562409
25.

Hemolytic uremic syndrome after high dose chemotherapy with autologous stem cell support.

van der Lelie H, Baars JW, Rodenhuis S, van Dijk MA, de Glas-Vos CW, Thomas BL, van Oers RH, von dem Borne AE.

Cancer. 1995 Dec 1;76(11):2338-42. Review.

PMID:
8635040
26.

Evaluation of the DPC IMMULITE random access immunoassay analyser.

Costongs GM, van Oers RJ, Leerkes B, Janson PC.

Eur J Clin Chem Clin Biochem. 1995 Nov;33(11):887-92.

PMID:
8620070
27.

Laboratory services utilization: a survey of repeat investigations in ambulatory care.

Branger PJ, Van Oers RJ, Van der Wouden JC, van der Lei J.

Neth J Med. 1995 Nov;47(5):208-13.

PMID:
8544891
28.

CD27-CD70 interaction: unravelling its implication in normal and neoplastic B-cell growth.

Lens SM, de Jong R, Hintzen RQ, Koopman G, van Lier RA, van Oers RH.

Leuk Lymphoma. 1995 Jun;18(1-2):51-9. Review.

PMID:
8580829
29.

Evaluation of performance characteristics of automated measurement systems for allergy testing.

Costongs GM, Janson PC, Hermans WJ, van Oers RJ, Leerkes B.

Eur J Clin Chem Clin Biochem. 1995 May;33(5):295-305.

PMID:
7578609
30.

Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin's lymphoma.

Verdonck LF, van Putten WL, Hagenbeek A, Schouten HC, Sonneveld P, van Imhoff GW, Kluin-Nelemans HC, Raemaekers JM, van Oers RH, Haak HL, et al.

N Engl J Med. 1995 Apr 20;332(16):1045-51.

31.

Evaluation of the Abbott automated random, immediate and continuous access immunoassay analyser, the AxSYM.

Costongs GM, van Oers RJ, Leerkens B, Hermans W, Janson PC.

Eur J Clin Chem Clin Biochem. 1995 Feb;33(2):105-11.

PMID:
7632821
32.

Corynebacterium CDC group JK (Corynebacterium jeikeium) sepsis in haematological patients: a report of three cases and a systematic literature review.

van der Lelie H, Leverstein-Van Hall M, Mertens M, van Zaanen HC, van Oers RH, Thomas BL, von dem Borne AE, Kuijper EJ.

Scand J Infect Dis. 1995;27(6):581-4. Review.

PMID:
8685637
33.

Granulocyte colony-stimulating factor administration to healthy volunteers: analysis of the immediate activating effects on circulating neutrophils.

de Haas M, Kerst JM, van der Schoot CE, Calafat J, Hack CE, Nuijens JH, Roos D, van Oers RH, von dem Borne AE.

Blood. 1994 Dec 1;84(11):3885-94.

PMID:
7524751
34.

Primary tumor cells of myeloma patients induce interleukin-6 secretion in long-term bone marrow cultures.

Lokhorst HM, Lamme T, de Smet M, Klein S, de Weger RA, van Oers R, Bloem AC.

Blood. 1994 Oct 1;84(7):2269-77.

PMID:
7919345
35.

Cytokines and intracellular signals involved in the regulation of B-CLL proliferation.

van Kooten C, Rensink I, Aarden L, van Oers R.

Leuk Lymphoma. 1993 Dec;12(1-2):27-33. Review.

PMID:
8161934
36.

TNF-alpha induces spreading of B-CLL via the CD11c/CD18 molecule.

van Kooten C, Rensink I, Aarden L, van Oers R.

Am J Hematol. 1993 Dec;44(4):221-8.

PMID:
7901991
37.

Recombinant granulocyte colony-stimulating factor administration to healthy volunteers: induction of immunophenotypically and functionally altered neutrophils via an effect on myeloid progenitor cells.

Kerst JM, de Haas M, van der Schoot CE, Slaper-Cortenbach IC, Kleijer M, von dem Borne AE, van Oers RH.

Blood. 1993 Dec 1;82(11):3265-72.

PMID:
7694676
38.

Interleukin-6 is a survival factor for committed myeloid progenitor cells.

Kerst JM, Slaper-Cortenbach IC, van der Schoot CE, Hooibrink B, von dem Borne AE, van Oers RH.

Exp Hematol. 1993 Nov;21(12):1550-7.

PMID:
7691639
39.

Differentiation of purified malignant B cells induced by PMA or by activated normal T cells.

van Kooten C, Rensink I, Aarden L, van Oers R.

Leukemia. 1993 Oct;7(10):1576-84.

PMID:
8105156
40.

Effect of IL-4 and IL-6 on the proliferation and differentiation of B-chronic lymphocytic leukemia cells.

van Kooten C, Rensink I, Aarden L, van Oers R.

Leukemia. 1993 Apr;7(4):618-24.

PMID:
8464239
41.

Granulocyte colony-stimulating factor induces hFc gamma RI (CD64 antigen)-positive neutrophils via an effect on myeloid precursor cells.

Kerst JM, van de Winkel JG, Evans AH, de Haas M, Slaper-Cortenbach IC, de Wit TP, von dem Borne AE, van der Schoot CE, van Oers RH.

Blood. 1993 Mar 15;81(6):1457-64.

PMID:
7680917
42.

Alpha 4 beta 1 and alpha 5 beta 1 are differentially expressed during myelopoiesis and mediate the adherence of human CD34+ cells to fibronectin in an activation-dependent way.

Kerst JM, Sanders JB, Slaper-Cortenbach IC, Doorakkers MC, Hooibrink B, van Oers RH, von dem Borne AE, van der Schoot CE.

Blood. 1993 Jan 15;81(2):344-51.

PMID:
7678511
43.

Combined measurement of growth and differentiation in suspension cultures of purified human CD34-positive cells enables a detailed analysis of myelopoiesis.

Kerst JM, Slaper-Cortenbach IC, von dem Borne AE, van der Schoot CE, van Oers RH.

Exp Hematol. 1992 Nov;20(10):1188-93.

PMID:
1385196
44.
45.

Both naive and memory T cells can provide help for human IgE production, but with different cytokine requirements.

van Kooten C, van der Pouw Kraan T, Rensink I, van Oers R, Aarden L.

Eur Cytokine Netw. 1992 May-Jun;3(3):289-97.

PMID:
1386757
46.
47.

Monokine production by human T cells; IL-1 alpha production restricted to memory T cells.

van Kooten C, Rensink I, Pascual-Salcedo D, van Oers R, Aarden L.

J Immunol. 1991 Apr 15;146(8):2654-8.

PMID:
1673143
48.

Human transferrin allows efficient IgE production by anti-CD3-stimulated human lymphocytes at low cell densities.

Van der Pouw-Kraan T, Van Kooten C, Van Oers R, Aarden LA.

Eur J Immunol. 1991 Feb;21(2):385-90.

PMID:
1825633
49.

Incidence and clinical epidemiology of streptococcal septicemia during treatment of acute myeloid leukemia.

van der Lelie H, van Ketel RJ, von dem Borne AE, van Oers RH, Thomas BL, Goudsmit R.

Scand J Infect Dis. 1991;23(2):163-8.

PMID:
1853164
50.

Complete remission of autoimmune thrombocytopenia after extirpation of a benign adenofibroma of the ovary.

von dem Borne AE, van Oers RH, Wiersinga WM, van der Tweel JG.

Br J Haematol. 1990 Jan;74(1):119-20. No abstract available.

PMID:
2310694

Supplemental Content

Loading ...
Support Center